🔎 Trials Near Me

Utama › Sarkoma Tisu Lembut › New York

Kajian klinikal Sarkoma Tisu Lembut di New York

27 kajian untuk Sarkoma Tisu Lembut sedang mencari peserta di lokasi di New York.

Bandar di New York

Teks kajian rasmi (Bahasa Inggeris)

A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell Sarcoma

  • Memorial Sloan Kettering Cancer Center, New York
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06942442

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Queens Hospital Center, Jamaica
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
  • Stony Brook University Medical Center, Stony Brook
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 40 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05334069

A Study of CRD3874-SI in People With Solid Tumors

  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
  • Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
  • dan 1 lagi
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Sep 2026 · NCT06021626

First-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma

  • Memorial Sloan Kettering Cancer Center, New York
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Sep 2026 · NCT06797999

Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

  • David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
Mengambil pesertaFasa 1
Umur 12 hingga 85 · Semua jantina · Dikemas kini 8 Sep 2026 · NCT03715933

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors

  • New York University Langone Health, New York
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Sep 2026 · NCT05732831

Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma

  • Memorial Sloan Kettering Cancer Center, New York
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Sep 2026 · NCT04577014

First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors

  • David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 4 Sep 2026 · NCT06644755

Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma

  • Montefiore Medical Center, The Bronx
Mengambil pesertaFasa 1/2
Umur 12 hingga 40 · Semua jantina · Dikemas kini 3 Sep 2026 · NCT07725380

A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

  • Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities), Commack
  • Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
  • dan 1 lagi
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Sep 2026 · NCT05837767

Actinium Therapy for Late-stage Aggressive Sarcomas

  • Memorial Sloane Kettering Cancer Center, New York
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Ogo 2026 · NCT07156565

STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas

  • Northwell Health Cancer Institute, Lake Success
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT06975293

Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases

  • Roswell Park Cancer Institute, Buffalo
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Ogo 2026 · NCT03965234

A Study of MGC026 in Participants With Advanced Solid Tumors

  • START-New York Long Island, Lake Success
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Ogo 2026 · NCT06242470

Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma

  • Memorial Sloan Kettering Commack (Consent and Follow-Up), Commack
  • Memorial Sloan Kettering Westchester (Consent and Followup), Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
  • dan 1 lagi
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 30 Jul 2026 · NCT00579566

A Study of Pembrolizumab in People With Ultra-Rare Sarcomas

  • Memorial Sloan Kettering Cancer Center Suffolk- Commack (Limited Protocol Activities), Commack
  • Memorial Sloan Kettering at Westchester (Limited Protocol Activities), Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
  • dan 1 lagi
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Jul 2026 · NCT07089992

Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors

  • Zai Lab Site 02002, New York
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Jul 2026 · NCT07374848

Integrated Cancer Repository for Cancer Research

  • C.R. Wood Cancer Center, Glens Falls Hospital, Glens Falls
  • Faxton St. Luke's Healthcare, Mohawk Valley, Utica
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 19 hingga 110 · Semua jantina · Dikemas kini 29 Jun 2026 · NCT02012699

Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People With Sarcoma

  • Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities ), Commack
  • Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
  • Memorial Sloan Kettering Cancer Center (All protocol activites), New York
  • dan 1 lagi
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Mei 2026 · NCT06129903

A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or Leg

  • Memorial Sloan Kettering Cancer Center @ Suffolk - Commack (Limited Protocol Activities), Commack
  • Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
  • Memorial Sloan Kettering Cancer Center, New York
  • dan 1 lagi
Mengambil pesertaFasa 2
Umur 12 ke atas · Semua jantina · Dikemas kini 23 Apr 2026 · NCT04332874

Brief Title Mechanisms of Cancer-Related Pain and Opioid Use Among Adolescents and Young Adult Sarcoma Survivors: Pilot Feasibility Study

  • Roswell Park Comprehensive Cancer Center, Buffalo
Mengambil pesertaKajian pemerhatian
Umur 12 hingga 70 · Semua jantina · Dikemas kini 15 Apr 2026 · NCT07402577

A Clinical Study to Investigate the Efficacy of Intratumoral Tigilanol Tiglate in Soft Tissue Sarcoma

  • Memorial Sloan Kettering Cancer Centre, New York
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 12 Mac 2026 · NCT05755113

Phase II Trial of Lung Chemoemobolization

  • Memorial Sloan Kettering Cancer Center, New York
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Mac 2026 · NCT05672108

Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma

  • Albert Einstein College of Medicine, Children's Hospital at Montefiore, The Bronx
  • New York Medical Center/ Maria Fareri Children's Hospital, Valhalla
Mengambil pesertaFasa 1/2
12 Months – 40 Years · Semua jantina · Dikemas kini 5 Feb 2026 · NCT03465592

Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma

  • Memorial Sloan Kettering Cancer Center, New York
Mengambil pesertaFasa 1/2
Umur 2 hingga 30 · Semua jantina · Dikemas kini 3 Feb 2026 · NCT05734066

A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

  • Children's Hospital at Montefiore, The Bronx
Mengambil pesertaFasa 2
18 Months – 40 Years · Semua jantina · Dikemas kini 12 Ogo 2025 · NCT05135975

Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.